Bisphosphonate-related osteonecrosis of the jaws an old disease with a new drug?
Eric R
ER
Carlson
D000284:Administration, Oral; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D004164:Diphosphonates / Q000009:adverse effects*; D042241:Early Diagnosis; D006801:Humans; D007275:Injections, Intravenous; D007571:Jaw Diseases / Q000139:chemically induced* / Q000175:diagnosis; D010020:Osteonecrosis / Q000139:chemically induced* / Q000175:diagnosis; D010024:Osteoporosis / Q000188:drug therapy; D018570:Risk Assessment; D012307:Risk Factors
D050071:Bone Density Conservation Agents; D004164:Diphosphonates